EPISODE · May 1, 2023 · 16 MIN
Rewind: A Promising Obesity Drug with Robert Kushner, MD
from Breakthroughs · host Northwestern University
This episode was released in February 2021, and is being re-shared to offer the research behind the popular weight loss drugs Ozempic and Wegovy. Northwestern's Robert Kushner, MD, discusses the drug semaglutide, typically prescribed for treatment of Type 2 diabetes and the results of the phase 3 clinical trial as a treatment for obesity with very promising results. The study was published in the New England Journal of Medicine, and in 2022, Kushner was awarded the prestigious Herbert Pardes Clinical Research Excellence Award from the Clinical Research Forum.
NOW PLAYING
Rewind: A Promising Obesity Drug with Robert Kushner, MD
No transcript for this episode yet
Similar Episodes
Apr 28, 2026 ·26m
Apr 28, 2026 ·68m
Apr 21, 2026 ·61m